Immune cells harvested from tumors could fight advanced cancers

NCT ID NCT05607095

First seen Jun 26, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This early-stage trial tests a personalized cell therapy called lifileucel for people with advanced uveal melanoma (a rare eye cancer) or certain sarcomas (connective tissue cancers). The treatment involves removing immune cells from the patient's tumor, growing them in a lab, and infusing them back after a short course of chemotherapy. The main goal is to check safety in 30 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Lifileucel (LN-144/LN-145) - a personalized cell therapy using the patient's own immune cells (tumor-infiltrating lymphocytes)
What this could lead to
If successful, this could point toward a new treatment option for advanced uveal melanoma and certain sarcomas that have not responded to standard therapies.
What could go wrong
This is a very early (Phase 1) trial with only 30 participants, so the main goal is safety, not effectiveness. The therapy involves intensive chemotherapy and high-dose IL-2, which can cause serious side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    RECRUITING

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Westchester

    RECRUITING

    Harrison, New York, 10604, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.